The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

About | Governance

The Doherty Council

The Doherty Institute is governed by the Doherty Council, which comprises of senior level executives from the University of Melbourne and the Royal Melbourne Hospital and the Director of the Institute.

The Doherty Council

Professor Sharon Lewin - Director

Leading infectious diseases expert Professor Sharon Lewin is the inaugural Director of the Doherty Institute. Sharon is an internationally renowned researcher in HIV cure and an infectious diseases physician. She leads a large, multi-disciplinary research team at the Doherty Institute that focuses on understanding why HIV persists on treatment and developing clinical trials aimed at ultimately finding a cure for HIV infection. She has published over 200 publications and has been continually funded by the NHMRC since 1993. She is an NHMRC Practitioner Fellow and also receives grant funding from the National Institutes of Health, the American Foundation for AIDS Research and the Wellcome Trust. She was local co-chair for the International AIDS Conference that was held in Melbourne in July 2014 (AIDS2014), which was the largest health conference ever hosted in Australia attracting 14,000 participants. She is a founding member of the Australian Academy of Health and Medical Sciences, a member of the NHMRC Council and Chair of the Health Translation Advisory Committee of the NHMRC. She was named Melburnian of the Year in 2014.

Professor Mark Hargreaves – Professor of Physiology and Dean of the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne

Mark Hargreaves is Professor of Physiology and Dean of the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne. Previous leadership roles at the University of Melbourne have included Head of the Department of Physiology (2009-2011), Program Director, Bachelor of Biomedicine (2006-2011) and Pro Vice-Chancellor, Research Partnerships (2011-2015, 0.5 fraction). Prior to his appointment as Professor of Physiology in 2005, he was Professor of Exercise Physiology at Deakin University (1996-2005) and was the inaugural Head of the Schools of Health Sciences (1999-2003) and Exercise and Nutrition Sciences (2004-2005). He has a Bachelor of Science in Physiology and PhD Physiology degree from the University of Melbourne and a Master of Arts in Exercise Physiology from Ball State University in the USA. He is a Fellow of the American College of Sports Medicine and Exercise and Sports Science Australia. He is currently an international representative on the Board of Trustees of the American College of Sports Medicine and is a member of the boards of Bionic Vision Australia, Oral Health CRC, Stem Cells Australia and the Victorian Institute of Sport.

Professor James McCluskey – Deputy Vice-Chancellor (Research), University of Melbourne

Professor James McCluskey is the Deputy Vice-Chancellor (Research) at the University of Melbourne, appointed in March 2011 and led the development of the Doherty Institute. Prior to this he was the Pro Vice-Chancellor, Research Partnerships and Chair of Microbiology and Immunology. 
James trained in Perth as a physician and pathologist. He spent four years at the National Institutes of Health in the USA. On returning to Australia in 1987 he worked at Monash University until 1991 before joining Flinders University and the Australian Red Cross Blood Service.
 James joined the University of Melbourne in 1997 and has an international reputation for his research in basic and clinical immunology and is recognised for his leadership in the field of human leukocyte antigens (HLA) and the major histocompatibility complex (MHC). He has consulted for the Australian Red Cross for more than 20 years and is Editor-in-Chief of the international immunogenetics journal, Tissue Antigens. He is on the Board of Directors of the Walter and Eliza Hall Institute, Florey Neuroscience Institutes, Bionics Institute and is Chair of the Nossal Institute Council and the Board of Nossal Institute Limited.

Dr Gareth Goodier – Chief Executive, Royal Melbourne Hospital

Dr Gareth Goodier is a public health physician who has served as the Chief Executive of several major health systems and academic hospitals for the last 25 years. He was appointed as the Chief Executive of Melbourne Health in June 2012. Gareth’s leadership of academic hospitals covers 18 years and includes Cambridge University Hospitals and the Women’s and Children’s Hospitals in Perth and Royal Perth Hospital. Gareth has also worked in the private sector as a management consultant for Arthur Andersen and the World Bank and has delivered university and college courses in Quality, Patient Safety and Contemporary Management. In 1995, Gareth received the Bernard Nicholson Prize for the ‘most outstanding candidate’ at the Royal Australasian College of Medical Administrators examination and in 2009 was recognised for his ‘continuing efforts to raise standards and improve performance within the global health arena’ with an Honorary Doctor of Health Science from Anglia Ruskin University, Cambridge. In January 2015, Gareth was awarded an Honorary Professorship by Jiao Tong University School of Medicine, Shanghai. Gareth has served on and has been the Chair of many boards including Medical Education England and also served as the President of the Women’s Hospitals Australasia and the Australasian Association of Paediatric Teaching Centres.

Professor Ingrid Winship – Executive Director Research, Royal Melbourne Hospital

Professor Ingrid Winship was appointed as the Executive Director Research for Melbourne Health and the Inaugural Chair of Adult Clinical Genetics at the University of Melbourne in November 2006. Ingrid graduated from the University of Cape Town in 1981 then completed postgraduate training in genetics and dermatology before combining an academic position at the University with a clinical position at the Groote Schuur Hospital from 1989-1994. In 1994, she moved to New Zealand to take an academic position at the University of Auckland where she later became Professor of Clinical Genetics. She was also Clinical Director of the Northern Regional Genetic Service in Auckland, which she initiated in 1995. In her last five years in Auckland she was Associate Dean for Research in the Faculty of Medicine and Health Sciences. Ingrid is currently a member of the Victorian Cancer Agency and on the Board of the Walter and Eliza Hall Institute. She is on the steering committee of the Melbourne Genomic Health Alliance, Scientific Advisor to the Human Variome Project and a member of the Strategic Advisory Council of the Kinghorn Centre for Clinical Genomics. She is a member of the Australian Health Ethics Committee of the National Health and Medical Research Council (NHMRC).